RSS feed

La Gazette du Laboratoire

Bluebird bio et Généthon annoncent une collaboration centrée sur le développement de vecteurs lentiviraux de thérapie génique

L’usine nouvelle

L´AFM inaugure son « usine » pour avancer dans les thérapies géniques

Le Quotidien du Médecin

Et maintenant la production de médicaments

20 Minutes

Les biomédicaments dans les gènes

Read the article [PDF]

Official Inauguration of Genethon Bioprod

Stimulated by the determination of the patients, in less than 20 years, Genethon, the laboratory of the Téléthon, has become a major actor in the development of therapies which stem from a knowledge of genes. Today, AFM (French muscular dystrophy association)‘s pioneer laboratory has taken up a new challenge of international scope: it has created … [Read more]


Téléthon : l’AFM change d’ère en inaugurant une usine de médicaments

Read the article [PDF]


Le Téléthon passe aux médicaments

Scientist are rallying for the AFM-Telethon

  Two weeks before the start of the Téléthon, 24 prominent French researchers are launching a manifesto to testify with one voice, the importance of the Telethon and the AFM’s contribution to the success of biomedical research. Just hours after its launch, 460 researchers had already joined and signed the petition. Excerpts: -“The most important … [Read more]

AFM Scientific Press Conference: First results of innovative therapies for rare diseases for the benefit of everyone

During a press conference that was held on November 18, 2010 at the Institute of Myology, Paris, AFM (French Association against Myopathie) summarized the first results which have been obtained thanks to innovative therapies (gene or cell therapy) used for rare disorders. Laurence Tiennot-Herment, President of AFM and Genethon and Frederic Revah, Managing Director of Genethon … [Read more]

Genethon present its “DMD” project in Milan

The 18th annual congress of the European Society of Gene and Cell Therapy (ESGCT) was held in Milan at the end of October. Genethon sponsors this event and Philippe Moullier, Scientific Director, presented one of Genethon’s major projects concerning Duchenne muscular dystrophy (DMD): a unique network of laboratories has been established to bring together the … [Read more]